Theodore Kee's Linkedin Analytics

As a kid, I was drawn to the kaiju stories and giant robots of the ’90s. The backstories of how the technology worked, especially when the bioengineered monsters or robots weren’t extraterrestrial in origin, fascinated me. Today, I combine this fascination with my desire to help people through biomedical devices – first surgical, nano, and now digital. I hold my MS in Bioengineering from UCLA and have worked in the United States & Singapore. My most recent experience has me conducting research and coordinating the group’s clinical trials nanodiamonds for enhanced therapeutic delivery and imaging, and a phenotypic personalized medicine (PPM) platform, termed CURATE.AI, that optimizes already given therapy regimens and develops novel therapeutic combinations for a myriad of indications, including oncology. Select Accolades: Forbes 30 Under 30, Asia for Healthcare & Science 2020. Obtained protocol approvals for fifteen first-in-human interventional clinical studies. Named finalist in both NIH DEBUT Challenge and ASAIOfyi. Secured three patents (2 US & 1 Singapore). I am a strong leader that develops teams of diverse people. I am analytical for both projects and organizations, understanding what drives motivation to promote empathy and team building. When asked about working with me, my colleague stated that I bring teammates to a greater height, and I am someone who can be trusted. Career Highlights: $22.6M+ in awarded grants/funding earned through excellent written and verbal communication skills. 18 papers published in leading journals such as Science Translational Medicine and Proceedings of the National Academy of Sciences (PNAS). Outside of the lab, you can find me at the gym, stand up comedy, cooking, scuba diving, traveling, or playing esports and Muay Thai.